Pallas Capital Advisors’s West Pharmaceutical WST Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.59M	Sell	6,359 -987	-13%	-$246K	0.06%	235
2025 Q4	$2.02M	Buy	7,346 +26	+0.4%	+$7.11K	0.07%	215
2025 Q3	$1.92M	Buy	7,320 +987	+16%	+$240K	0.07%	215
2025 Q2	$1.39M	Buy	6,333 +62	+1%	+$13.3K	0.05%	257
2025 Q1	$1.4M	Sell	6,271 -30	-0.5%	-$8.27K	0.06%	240
2024 Q4	$2.06M	Buy	6,301 +8	+0.1%	+$2.52K	0.09%	155
2024 Q3	$2.08M	Sell	6,293 -1	-0%	-$306	0.09%	151
2024 Q2	$1.99M	Buy	6,294 +5	+0.1%	+$1.77K	0.09%	153
2024 Q1	$2.49M	Sell	6,289 -6	-0.1%	-$2.22K	0.1%	142
2023 Q4	$2.22M	Sell	6,295 -6	-0.1%	-$2.12K	0.12%	134
2023 Q3	$2.02M	Buy	6,301 +11	+0.2%	+$4.25K	0.12%	138
2023 Q2	$2.41M	Buy	6,290 +15	+0.2%	+$5.36K	0.11%	114
2023 Q1	$2.33M	Sell	6,275 -3	-0%	-$877	0.22%	88
2022 Q4	$1.63M	Sell	6,278 -57	-0.9%	-$13.5K	0.16%	105
2022 Q3	$1.33M	Buy	6,335 +2,000	+46%	+$609K	0.15%	110
2022 Q2	$1.36M	Hold	4,335	–	–	0.19%	95
2022 Q1	$1.65M	Buy	+4,335	New	+$1.7M	0.21%	90